REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS

Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal definition of a rare disease and no universal approach to orphan drugs legislation. As a result, decision-making in this field requires results of pharmacoeconomic analysis, which structure and interpretatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev
Formato: Artigo
Idioma:Russo
Publicado em: IRBIS LLC 2015-09-01
Colecção:Фармакоэкономика
Assuntos:
pharmacoeconomics
orphan drugs
rare diseases
cost-utility analysis
Acesso em linha:https://www.pharmacoeconomics.ru/jour/article/view/98
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados